S. Rydén
Impact in
- Oncology top 5%
- Global Cancer Incidence and Screening
- Colorectal Cancer Screening and Detection
- Cancer Risks and Factors
- Cancer Research top 10%
- Breast Cancer Treatment Studies
Papers in
- Co-authors
- M. Lindqvist (1 shared paper)Nils Bjurstam (1 shared paper)L. E. Rutqvist (1 shared paper)A. Lindgren (1 shared paper)J. Andersson (1 shared paper)Lars‐Gunnar Larsson (1 shared paper)Stig Wall (1 shared paper)G Fagerberg (1 shared paper)
- Journals
- Acta Oncologica (2 papers)Scandinavian Journal of Gastroenterology (1 paper)Bone (1 paper)The Lancet (1 paper)Intensive and Critical Care Nursing (1 paper)
- Partner nations
- SwedenUnited StatesGermany
In The Last Decade
S. Rydén
18 papers receiving 981 citations
S. Rydén's Hit Papers
Peers
Comparison fields: 5 of 90
- Oncology 680
- Cancer Research 187
- Pathology and Forensic Medicine 95
- Genetics 135
- Radiology, Nuclear Medicine and Imaging 76
Countries citing papers authored by S. Rydén
This map shows the geographic impact of S. Rydén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Rydén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Rydén more than expected).
Fields of papers citing papers by S. Rydén
This network shows the impact of papers produced by S. Rydén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Rydén. The network helps show where S. Rydén may publish in the future.
Co-authors
The 25 scholars most cited alongside S. Rydén, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Breast cancer screening with mammography: overview of Swedish randomised trials Hit paper breakdown → | 1993 | 743 |
| 2 | 1996 | 70 | |
| 3 | 1998 | 45 | |
| 4 | 1990 | 45 | |
| 5 | 1985 | 45 | |
| 6 | 1996 | 27 | |
| 7 | 1978 | 26 | |
| 8 | Phase II study of high dose toremifene in advanced breast cancer progressing during tamoxifene treatment. | 1991 | 19 |
| 9 | Low anterior resection using stapling instrument. | 1979 | 14 |
| 10 | 1986 | 10 | |
| 11 | 1995 | 8 | |
| 12 | 1985 | 5 | |
| 13 | The 1987 Comprehensive Blood Bank Survey of the College of American Pathologists. | 1989 | 4 |
| 14 | 1985 | 3 | |
| 15 | The 1989 Comprehensive Blood Bank Survey of the College of American Pathologists. | 1992 | 3 |
| 16 | Weekly dose adriamycin as first line chemotherapy in advanced breast cancer. | 1991 | 3 |
| 17 | 1995 | 2 | |
| 18 | 1995 | 1 |
About S. Rydén
S. Rydén is a scholar working on Oncology, Surgery, Hematology, Genetics and Hepatology, having authored 18 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Diagnosis and Treatment (4 papers), Bone health and treatments (4 papers), Blood groups and transfusion (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Breast Cancer Treatment Studies (2 papers), Bone health and osteoporosis research (2 papers), Pediatric Hepatobiliary Diseases and Treatments (2 papers) and Estrogen and related hormone effects (2 papers). The work is most often cited by research in Oncology (680 citations), Cancer Research (187 citations), Pathology and Forensic Medicine (95 citations), Genetics (135 citations) and Radiology, Nuclear Medicine and Imaging (76 citations). S. Rydén has collaborated with scholars based in Sweden, United States and Germany. Frequent co-authors include M. Lindqvist, Nils Bjurstam, L. E. Rutqvist, A. Lindgren, J. Andersson, Lars‐Gunnar Larsson, Stig Wall, G Fagerberg, L. Nyström and L. Tabár. Their work appears in journals such as Acta Oncologica, Scandinavian Journal of Gastroenterology, Bone, The Lancet and Intensive and Critical Care Nursing.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.